Drugs Made In Stock Today
| DMAA Stock | 10.38 0.01 0.1% |
PerformanceGood
| Odds Of DistressLow
|
Drugs Made is trading at 10.38 as of the 6th of January 2026, a 0.1 percent up since the beginning of the trading day. The stock's open price was 10.37. Drugs Made has only a 7 % chance of going through financial distress over the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 7th of December 2025 and ending today, the 6th of January 2026. Click here to learn more.
Business Domain Financial Services | IPO Date 25th of February 2025 | Classification Financials |
Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 33.52 M outstanding shares of which 41.98 K shares are currently shorted by private and institutional investors with about 4.26 trading days to cover. More on Drugs Made In
Moving together with Drugs Stock
| 0.68 | DB | Deutsche Bank AG | PairCorr |
| 0.66 | DRDB | Roman DBDR Acquisition | PairCorr |
| 0.76 | ALF | Centurion Acquisition | PairCorr |
| 0.62 | UBS | UBS Group AG | PairCorr |
Moving against Drugs Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Drugs Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Chairman | Lynn Stockwell |
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Diversified Capital Markets, Financial Services, NASDAQ Composite, Drugs, Financials, Capital Markets, Shell Companies, Industrials (View all Sectors) |
| Financial Strength | |
Drugs Made In (DMAA) is traded on NASDAQ Exchange in USA and employs 3 people. Drugs Made is listed under Diversified Capital Markets category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 347.91 M. Drugs Made In conducts business under Capital Markets sector and is part of Financials industry. The entity has 33.52 M outstanding shares of which 41.98 K shares are currently shorted by private and institutional investors with about 4.26 trading days to cover.
Check Drugs Made Probability Of Bankruptcy
Ownership AllocationDrugs Made holds a total of 33.52 Million outstanding shares. Over half of Drugs Made's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Drugs Ownership Details
Drugs Made Historical Income Statement
Drugs Stock Against Markets
Drugs Made Corporate Executives
Elected by the shareholders, the Drugs Made's board of directors comprises two types of representatives: Drugs Made inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Drugs. The board's role is to monitor Drugs Made's management team and ensure that shareholders' interests are well served. Drugs Made's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Drugs Made's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Saleem CPA | CFO Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Drugs Made In. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.